Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
latanoprost ocular implant (PA5108) / PolyActiva
ACTRN12621001718831p: Phase I study of a Latanoprost Ocular Implant for treatment of Open Angle Glaucoma or Ocular Hypertension.	Not yet recruiting	1	6			PolyActiva Pty Ltd, PolyActiva Pty Ltd	Open Angle Glaucoma; Ocular Hypertension
ACTRN12621001718831: Phase I study of a Latanoprost Ocular Implant for treatment of Open Angle Glaucoma or Ocular Hypertension.	Recruiting	1	6			PolyActiva Pty Ltd, PolyActiva Pty Ltd	Open Angle Glaucoma, Ocular Hypertension
NCT05333419: Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.	Completed	1	1	RoW	100ng/day PA5346 Latanoprost FA SR Ocular Implant	PolyActiva Pty Ltd	Open Angle Glaucoma, Ocular Hypertension	06/23	09/23
NCT04060758: Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma	Active, not recruiting	1	37	RoW	PA5108 Latanoprost FA SR Ocular Implant, PA5108	PolyActiva Pty Ltd	Open Angle Glaucoma	09/24	02/25